Melvin L.K. Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of Radiation Oncology at National Cancer Centre Singapore, shared a post on LinkedIn:
“First time in the Middle East at the invitation of Prof. Humaid Al-Shamsi
Glad to be part of an illustrious panel discussing AI and Data in Clinical Decision Making in the Cancer Oncology space
Key points:
- RWD can potentially be controls of large Ph3 RCTs and mitigate cost of Clinica lTrials
- AI models could facilitate clinical decision making in Raredisease
- Need for demographics diversity in RWD which is also most challenging bit
- Elephant in the room is of course whether AIbots will replace Humans – Glad to see that the room was divided on this so there’s hope!
Once again, was an eye opener to witness innovations across all healthcare domains…
Till next time!”
Other articles featuring Melvin L.K. Chua on OncoDaily.
